Corient Private Wealth’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Buy
22,727
+6,288
+38% +$169K ﹤0.01% 1936
2026
Q1
$350K Sell
16,439
-446
-3% -$10.5K ﹤0.01% 2241
2025
Q4
$548K Buy
16,885
+87
+0.5% +$3.73K ﹤0.01% 1822
2025
Q3
$953K Sell
16,798
-1,350
-7% -$69.2K ﹤0.01% 1453
2025
Q2
$905K Buy
18,148
+7,016
+63% +$317K ﹤0.01% 1410
2025
Q1
$329K Buy
+11,132
New +$414K ﹤0.01% 1808

Other funds holding HIMS

Corient Private Wealth's HIMS Position: Q2 2026 in Review

Corient Private Wealth increased its Hims & Hers Health (HIMS) stake by 38% in Q2 2026, buying an estimated $169K and bringing the position to 22,727 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

Corient Private Wealth first reported a position in HIMS in Q1 2025 and has held it in 6 quarters since. The position peaked at $953K in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Corient Private Wealth held 22,727 shares of Hims & Hers Health worth $788K as of Q2 2026.
  • Corient Private Wealth bought 6,288 Hims & Hers Health shares in Q2 2026, an estimated $169K.
  • Hims & Hers Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1936 holding.
  • Corient Private Wealth first reported a position in Hims & Hers Health in Q1 2025 and has held it in 6 quarters since.
  • Corient Private Wealth's Hims & Hers Health position peaked at $953K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.